IDO enzyme and IL-10 to TNF-α ratios as immune response silicone granuloma: Predictors factors
DOI:
https://doi.org/10.66344/jpad.32.2.2022.1791Abstract
Background Silicones are still being commonly used in medicine, whether in filling materials or their mixture. Some may penetrate human body tissue through injections or application with advanced medical technology, particularly transdermal administration. The study was aimed to determine predictor factors to assess the immune response to silicone filler injection. Â Methods An analytical cross-sectional study was conducted to evaluate immune response based on blood in patients with granuloma following silicone injection compared to normal patients; The materials included blood cultures with RPMI media, which were categorized into three groups, i.e. RPMI alone, with PHA and with 3% silicone groups. Evaluation on immune response was performed by analyzing IDO enzyme using ELISA and detecting TNF-a, IFN-g, IL-10 cytokines using the Luminex technology. The study was conducted at Eijkman Foundation Laboratory, Faculty of Medicine, the University of Indonesia, between 2012 and 2015. Â Results Patients with granuloma had higher levels of proinflammatory cytokines in their blood, and the ratios of TNF-a/IL-10 and TNF-a/IDO in blood were significantly different between patients with granuloma and standard control. Â Conclusion IL-10 and IDO enzyme play critical roles in immune tolerance caused by silicone injection and can be utilized as predictors to assess immune response induced by silicone injection. ÂDownloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.